SVM-90
1 paper studies it2 findings
- Humans1
Associations
2Cardiovascular mortality
downin humans1HR 0.43
1 study
Cardiovascular mortality
downin humans1HR 0.43
SVM-90 lowers the risk of cardiovascular mortality in humans (HR 0.43 (0.23-0.79), p=0.00676).
“and CV mortality (HR 0.43 (0.23-0.79), p=0.00676, Fig.1B) compared to the low SVM-90 group”
Humansheart failure, adjusted for MIMS above or below the medianmean 5.4 years50.9% femalesn = 291
AHA Scientific Sessions 2025 abstract
Mortality
downin humans1HR 0.56
1 study
Mortality
downin humans1HR 0.56
SVM-90 lowers the risk of mortality in humans (HR 0.56 (0.38-0.84), p=0.00444).
“In models adjusted for MIMS above or below the median, the high SVM-90 group presented reduced risk of all-cause (HR 0.56 (0.38-0.84), p=0.00444, Fig.1A)”
Humansheart failure, adjusted for MIMS above or below the medianmean 5.4 years50.9% femalesn = 291
AHA Scientific Sessions 2025 abstract
Latest
1 paper in 12 monthsAHA Scientific Sessions 2025 Abstract
Near-Maximal Movement Captured by Accelerometry Offers Superior Mortality Risk Prediction Than Aggregate Movement in Heart Failure
Cohort study of 291 peopleHeart failure